Two studies led by The University of Texas MD Anderson Cancer Center that shed new light on the potential of the gut microbiome as a targetable biomarker to improve responses to immunotherapy were presented today…
in Health
Studies reveal new insights into gut microbiome impact on immunotherapy response in multiple cancers
